HUP0002752A2 - Egy szekréciós vektor alkalmazása termékenység-szabályozásra orális vakcinálással - Google Patents

Egy szekréciós vektor alkalmazása termékenység-szabályozásra orális vakcinálással

Info

Publication number
HUP0002752A2
HUP0002752A2 HU0002752A HUP0002752A HUP0002752A2 HU P0002752 A2 HUP0002752 A2 HU P0002752A2 HU 0002752 A HU0002752 A HU 0002752A HU P0002752 A HUP0002752 A HU P0002752A HU P0002752 A2 HUP0002752 A2 HU P0002752A2
Authority
HU
Hungary
Prior art keywords
fertility control
oral vaccination
secretion vector
vaccination
oral
Prior art date
Application number
HU0002752A
Other languages
English (en)
Hungarian (hu)
Inventor
Andreas Demuth
Peter Donner
Ivaylo Gentschev
Werner Goebel
Jürgen Hess
Stefan Kaufmann
Original Assignee
Schering Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag. filed Critical Schering Ag.
Publication of HUP0002752A2 publication Critical patent/HUP0002752A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HU0002752A 1997-05-07 1998-05-07 Egy szekréciós vektor alkalmazása termékenység-szabályozásra orális vakcinálással HUP0002752A2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19720761A DE19720761A1 (de) 1997-05-07 1997-05-07 Verfahren zur Synthese und Sekretion von zur Kontrazeption geeigneter Proteine oder Proteinfragmente durch attenuierte Salmonellen oder einen anderen Gram-negativen attenuierten Impfstamm zur Erzeugung einer oralen Vakzinierung

Publications (1)

Publication Number Publication Date
HUP0002752A2 true HUP0002752A2 (hu) 2000-12-28

Family

ID=7829783

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002752A HUP0002752A2 (hu) 1997-05-07 1998-05-07 Egy szekréciós vektor alkalmazása termékenység-szabályozásra orális vakcinálással

Country Status (18)

Country Link
EP (1) EP1015023A1 (zh)
JP (1) JP2002501507A (zh)
KR (1) KR20010012257A (zh)
CN (1) CN1255067A (zh)
AU (1) AU7910798A (zh)
BG (1) BG103850A (zh)
BR (1) BR9809244A (zh)
CA (1) CA2288602A1 (zh)
DE (1) DE19720761A1 (zh)
EE (1) EE9900516A (zh)
HU (1) HUP0002752A2 (zh)
IL (1) IL132521A0 (zh)
IS (1) IS5199A (zh)
NO (1) NO995429L (zh)
PL (1) PL336786A1 (zh)
SK (1) SK151799A3 (zh)
TR (1) TR199902671T2 (zh)
WO (1) WO1998050067A2 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10206325A1 (de) * 2002-02-14 2003-09-04 Medinnova Ges Med Innovationen Ummantelter Mikroorganismus
US6989160B2 (en) * 2002-03-19 2006-01-24 Council Of Scientific And Industrial Research Therapeutic/edible compositions comprising herbal ingredients and methods for treating hyperglycemia
WO2006121165A1 (ja) * 2005-05-12 2006-11-16 Ajinomoto Co., Inc. タンパク質の製造法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992009684A1 (en) * 1990-11-21 1992-06-11 Washington University Recombinant avirulent salmonella antifertility vaccines
US5480799A (en) * 1993-12-10 1996-01-02 The University Of North Carolina At Chapel Hill Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope

Also Published As

Publication number Publication date
EE9900516A (et) 2000-06-15
CA2288602A1 (en) 1998-11-12
TR199902671T2 (xx) 2000-09-21
EP1015023A1 (de) 2000-07-05
PL336786A1 (en) 2000-07-17
WO1998050067A2 (de) 1998-11-12
WO1998050067A9 (de) 1999-03-25
JP2002501507A (ja) 2002-01-15
KR20010012257A (ko) 2001-02-15
NO995429L (no) 2000-01-07
AU7910798A (en) 1998-11-27
WO1998050067A3 (de) 2000-06-29
SK151799A3 (en) 2000-06-12
CN1255067A (zh) 2000-05-31
NO995429D0 (no) 1999-11-05
IS5199A (is) 1999-09-28
BG103850A (en) 2000-05-31
DE19720761A1 (de) 1998-11-12
BR9809244A (pt) 2000-06-27
IL132521A0 (en) 2001-03-19

Similar Documents

Publication Publication Date Title
DK1104306T3 (da) Præparater af CpG- og saponinadjuvanser og fremgangsmåder til anvendelse deraf
TW266228B (zh)
PT865297E (pt) Composicoes de vacinas para administracao intranasal compreendendo quitosano e suas utilizacoes
EP1594536A4 (en) ADJUVANT INFLUENZA VACCINE
SG152917A1 (en) Neisseria meningitidis antigens
NO991524L (no) Vaksiner
CY2570B1 (en) Compounds for immunotherapy and diagnosis of tuberculosis
AU3526995A (en) Vaccine compositions
FI102382B1 (fi) Ilmentämisjärjestelmä ihmisen respiratory syncytial -viruksen glykoproteiinien immunogeenisia fragmentteja sisältäviä kimeerisiä glykoproteiineja varten
GB9808327D0 (en) Antidiotypic compounds
HUP9801223A2 (hu) Eljárás specifikus antigénekre adott antitest válasz fokozására interleukin-10-zel
DK0701612T3 (da) Immunogent præparat af OspC-antigenvacciner til forebyggelse og behandling af Lyme sygdom og rekombinantmetode til fremsti
DK1112747T3 (da) Salmonellavaccine, som ikke inducerer antistoffer mod flagellin eller flageller
HUP0002752A2 (hu) Egy szekréciós vektor alkalmazása termékenység-szabályozásra orális vakcinálással
NZ335050A (en) Helicobacter pylori live vaccine
WO2000050073A3 (en) Caulobacter lps immunoadjuvant
DK0975360T3 (da) Bovint respiratorisk og enterisk coronavirus som vaccine
NZ295877A (en) A vaccine comprising the helicobacter bacterium and its use
AU6761301A (en) Adjuvant composition comprising fha protein or fragment of fha protein in free form
AU2579600A (en) Product and method for obtaining specific immunisation with one or more antigens
WO2001035993A3 (en) Compositions and methods for stimulating an immune response against infectious agents
AU2415899A (en) Intranasal yellow fever vaccination
SE9600646D0 (sv) Vaccin
PL341541A1 (en) Isolated strains of staphyloccoccus aureus and vaccines prepared of them
Erume et al. Evaluation of the adjuvant effect of Escherichia coli heat-labile enterotoxin mutant (LTK63) on the systemic immune responses to intranasally co-administered measles virus nucleoprotein. Part I: antibody responses